Healthcare Costs

U.S. CMS creates new reimbursement category for stroke patients

Published in Pharma Law Weekly, September 13th, 2005

The U.S. Centers for Medicare and Medicaid Services (CMS) has created a new diagnostic code to reimburse hospitals at a higher rate for acute ischemic stroke patients treated with a thrombolytic agent, or a clot-busting drug. An ischemic stroke is typically caused by a blood clot.

"This is a victory for those suffering a stroke. The American Stroke Association advocates for effective treatment and improved systems of care of stroke patients. This new code will provide hospitals with appropriate reimbursement for the higher costs related to the treatment of ischemic stroke patients with a clot-busting drug, which may help reduce debilitating effects from the stroke,"...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2005-09-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry